Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Roth

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2025
Acid excretion is impaired in calcium oxalate stone formersPedro H Imenez Silva, Nasser A Dhayat, Daniel G Fuster, et al.
Plos One|October 16, 2025
Partial volume effect on kidney stones and lung nodules in CT imagingAndreas Christe, Beat Roth, Daniel Guido Fuster, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
BJU International|October 18, 2013
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapyPascal Zehnder, Urs E Studer, Siamak Daneshmand, et al.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.
European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.
Plos One|August 4, 2025
Incidental findings on non-contrast abdominal computed tomography in an asymptomatic population: Prevalence, economic and health implicationsAlexander Ritter, Maximilian Sabev, Olivier Bonny, et al.
World Journal of Urology|September 15, 2023
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocolSandy Schaer, Arnas Rakauskas, Julien Dagher, et al.
World Journal of Urology|January 28, 2026
How safe is teaching radical cystectomy? : Results from the prospective Swiss society of urology databaseMatteo Scherrer, Lujza Brunaiova, Marc Furrer, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2025
Acid excretion is impaired in calcium oxalate stone formersPedro H Imenez Silva, Nasser A Dhayat, Daniel G Fuster, et al.
Plos One|October 16, 2025
Partial volume effect on kidney stones and lung nodules in CT imagingAndreas Christe, Beat Roth, Daniel Guido Fuster, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
BJU International|October 18, 2013
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapyPascal Zehnder, Urs E Studer, Siamak Daneshmand, et al.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.
European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.
Plos One|August 4, 2025
Incidental findings on non-contrast abdominal computed tomography in an asymptomatic population: Prevalence, economic and health implicationsAlexander Ritter, Maximilian Sabev, Olivier Bonny, et al.
World Journal of Urology|September 15, 2023
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocolSandy Schaer, Arnas Rakauskas, Julien Dagher, et al.
World Journal of Urology|January 28, 2026
How safe is teaching radical cystectomy? : Results from the prospective Swiss society of urology databaseMatteo Scherrer, Lujza Brunaiova, Marc Furrer, et al.
Pageof 14